论文信息 - Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry - 字舞流文

Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry

F. Salaffi | P. Sarzi-Puttini | S. Bugatti | F. Atzeni | E. Galli | E. Favalli | E. Fusaro | G. Lopalco | B. Frediani | F. Iannone | G. Ferraccioli | M. Biggioggero | R. Foti | G. Lapadula | E. Gremese | F. Conti | F. Cantatore | A. Manfredi | M. Sebastiani | A. Cauli | A. Bortoluzzi | L. Petricca | C. Lomater | S. Balduzzi | A. Carletto | C. Bazzani | V. Venerito | R. Gorla | E. Visalli | Elena Francesco Paolo Claudia Fabiola Roberto Enrico Fau Galli Cantatore Lomater Atzeni Gorla Fusaro